Randi G Syljuåsen

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 30, 2026
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential.

|Jan 22, 2026
Transcription termination counteracts DNA damage after WEE1 inhibition.

Helga B Landsverk, Lise E Sandquist, Lilli T E Bay

|May 24, 2021
New link between the RNA polymerase II-CTD and replication stress.

Helga B Landsverk, Lise E Sandquist, Lilli T E Bay

|Apr 20, 2021
Expanding roles of cell cycle checkpoint inhibitors in radiation oncology.

Sissel Hauge, Adrian Eek Mariampillai, Gro Elise Rødland

|Apr 05, 2019
p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775.

Sissel Hauge, Libor Macurek, Randi G Syljuåsen

Pageof 1

Frequent Collaborators

1 joint publications

Libor Macurek

1 joint publications

Chakravarthi Kanduri

1 joint publications

Pilar Ayuda-Durán

1 joint publications

Robert Hanes